At NOVOS, we’ve always prided ourselves on setting the gold standard in the consumer longevity space. Today, I’m thrilled to share an achievement that underscores our commitment to science and innovation: NOVOS has been accepted into the Longevity Biotech Association (LBA). Among an elite group of companies, NOVOS is the only over-the-counter, natural supplement brand to join this prestigious organization.
This milestone is more than just a membership—it’s a testament to the rigorous scientific foundation upon which NOVOS is built. It also distinguishes us as the leader in a field cluttered with unproven claims and products that often fall short of delivering meaningful results.
Why the Longevity Biotech Association Matters
The Longevity Biotech Association is the epicenter of innovation for aging science, uniting global leaders in biotechnology, research, and investment. With its mission to set industry standards, the LBA works tirelessly to ensure that longevity breakthroughs translate into real-world healthspan and lifespan extensions.
Its vision—one we wholeheartedly align with—is a future where aging is recognized as the primary driver of most diseases. Through targeting scientifically validated aging pathways, the LBA advocates for regulatory acceptance of gerotherapeutics to benefit all of humanity. Our acceptance into this esteemed organization reflects the strength of our science and our commitment to transforming the way we age.
What Sets NOVOS Apart
When I founded NOVOS, my vision was clear: create a consumer longevity brand rooted in science, not hype. The supplement industry, particularly the longevity segment, is rife with products promising miracles but delivering little. NOVOS takes the opposite approach—putting science first and letting the results speak for themselves.
Here’s what makes us different:
Evidence-Based Formulations: Every ingredient in NOVOS products is selected based on robust scientific evidence. We rigorously test our formulations, conducting clinical trials and collaborating with leading researchers worldwide.
Third-Party Validation: Unlike many competitors, NOVOS undergoes scrutiny from independent labs and academic institutions. Our results aren’t just marketing claims—they’re peer-reviewed, measurable, and reproducible.
Proven Outcomes: NOVOS supplements have been shown to slow biological aging. In a recent case study, 73% of participants who used NOVOS Core reduced their pace of aging, with none experiencing an acceleration. Results like these are not just uncommon—they’re unparalleled in the consumer longevity space.
Redefining the Standards of Longevity Supplements: Many products in the market today rely on outdated science or buzzwords like “anti-aging.” While some may work on a surface level, few address the root causes of aging or demonstrate measurable impacts on biological age.
At NOVOS, we challenge this status quo by setting a higher bar for accountability and results. Our inclusion in the Longevity Biotech Association reinforces what we’ve always known: NOVOS isn’t just another supplement company. We’re a biotech-driven movement to extend human healthspan and lifespan.
Closing Thoughts
Joining the Longevity Biotech Association is a moment of pride, but it’s also a call to action. We remain steadfast in our mission to democratize access to scientifically validated solutions for aging. While others may choose shortcuts, we choose science.
To our customers and supporters: thank you for trusting us on this journey. And to those exploring ways to optimize their longevity—know that with NOVOS, you’re in the hands of a company that prioritizes science, integrity, and your future. At NOVOS, we don’t just slow the clock; we redefine what it means to age.
Here’s to living longer—and better.